These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11031208)

  • 1. c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury.
    Kupatt C; Habazettl H; Hanusch P; Wichels R; Hahnel D; Becker BF; Boekstegers P
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2226-32. PubMed ID: 11031208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia--reperfusion injury.
    Habazettl H; Hanusch P; Kupatt C
    Z Kardiol; 2000; 89 Suppl 9():IX/92-5. PubMed ID: 11151804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
    Campbell B; Chuhran CM; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction.
    Götz AK; Zahler S; Stumpf P; Welsch U; Becker BF
    Basic Res Cardiol; 2005 Sep; 100(5):413-21. PubMed ID: 15944806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury.
    Kupatt C; Habazettl H; Zahler S; Weber C; Becker BF; Messmer K; Gerlach E
    Cardiovasc Res; 1997 Dec; 36(3):386-95. PubMed ID: 9534860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.
    Kuo YR; Jeng SF; Wang FS; Huang HC; Wei FC; Yang KD
    J Surg Res; 2002 Sep; 107(1):50-5. PubMed ID: 12384064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion.
    Bertuglia S; Giusti A
    BMC Cardiovasc Disord; 2002 Jun; 2():10. PubMed ID: 12086588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts.
    Heindl B; Zahler S; Welsch U; Becker BF
    Cardiovasc Res; 1998 May; 38(2):383-94. PubMed ID: 9709399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
    Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
    Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMN/platelets coinfused in guinea pig hearts Exposed to low-flow ischemia have no additive cardiodepressive effect.
    Seligmann C; Leitsch T; Kusus M; Bock A; Schimmer M; Simsek Y; Daniel WG
    J Vasc Res; 2003; 40(6):501-8. PubMed ID: 14631104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
    Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-selectin expression on platelets determines size and stability of platelet aggregates.
    Merten M; Thiagarajan P
    Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart.
    Szekely A; Heindl B; Zahler S; Conzen PF; Becker BF
    Anesth Analg; 2000 Jun; 90(6):1293-300. PubMed ID: 10825310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.